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Glucocorticoids are lower at 
delivery in maternal, but not cord 
blood of obese pregnancies
Laura I. Stirrat1, George Just2, Natalie Z. M. Homer  2, Ruth Andrew  2,3, Jane E. Norman1 & 
Rebecca M. Reynolds1,3
Glucocorticoids are vital for lung maturation. We previously showed that cortisol is lower in obese 
pregnancy. Whether this is maintained at delivery is unknown but is clinically relevant as maternal 
and cord blood cortisol levels are correlated and offspring of obese are more likely to need neonatal 
respiratory support. We hypothesized that glucocorticoids are lower in maternal and cord blood at 
delivery in obese pregnancies. Glucocorticoids (cortisol and corticosterone) and their inactive versions 
(cortisone and 11-dehydrocorticosterone) were measured by LC-MS/MS in maternal and cord plasma 
from 259 Caucasian women at delivery (BMI 18–55 kg/m2). Analyses adjusted for labour status, 
delivery mode, offspring gender, birthweight and gestational age. Cortisol and corticosterone were 
significantly higher in maternal than cord blood. Inactive versions were significantly higher in cord than 
maternal blood. Increased maternal BMI associated with lower maternal cortisol, corticosterone and 
11-dehydrocorticosterone. Despite significant positive correlations between maternal and cord blood 
glucocorticoid levels, increased maternal BMI was not associated with lower cord blood glucocorticoid 
levels. Conditions at delivery may overcome any potential negative effects of low maternal 
glucocorticoids on the fetus in the short-term. This may not preclude the longer-term effects of fetal 
exposure to lower glucocorticoid levels during obese pregnancy.
Glucocorticoids are vital for fetal growth and lung maturation. This has been demonstrated therapeutically when 
glucocorticoids are administered antenatally to women at threat of preterm labour with consequent reduced 
respiratory morbidity in both extremely preterm1, and nearer term babies2. We and others have shown that cir-
culating maternal cortisol levels are lower in obese compared with lean women during pregnancy3–5 and post-
partum3. Whether or not lower maternal cortisol levels in obese are maintained at delivery is clinically relevant 
as maternal and cord blood cortisol levels are correlated6–8. As offspring born to obese women are more likely to 
need respiratory support at delivery9, it is plausible that exposure to comparatively lower levels of glucocorticoids 
in utero could limit fetal lung maturation in this group. One previous study reported lower maternal cortisol, but 
not cord cortisol at delivery in obese compared to normal weight women4, but did not adjust for mode of delivery 
or labour; both factors are known to influence cord cortisol levels10–14.
While cortisol is the major circulating glucocorticoid hormone in humans, there is increasing interest in the 
potential physiological roles of corticosterone, which comprises 5–10% of total plasma glucocorticoids15. The 
observation of proportionally greater increases in cord blood corticosterone than cortisol according to ‘stressful’ 
labour and mode of delivery has led to the suggestion that the full-term human fetus preferentially secretes cor-
ticosterone in response to fetal stress14.
To our knowledge there are no studies measuring maternal corticosterone levels at time of delivery and it is 
not known whether corticosterone levels differ in obese and lean pregnancy. Both cortisol and corticosterone 
can freely cross the placenta from mother to fetus, and are metabolised to their inactive forms (cortisone and 
11-dehydrocorticosterone, respectively) by the placental enzyme 11beta-hydroxysteroid dehydrogenase type 2 
(11β-HSD2).
We hypothesized that cortisol and corticosterone levels measured at the time of delivery would be lower in the 
maternal and cord blood of obese pregnancies than lean, even after adjusting for potentially confounding factors 
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such as labour and mode of delivery. We tested this hypothesis by testing associations of maternal BMI with corti-
sol, corticosterone and their metabolites, measured in maternal and cord blood samples obtained at delivery from 
women across a range of obesity levels.
Method
Clinical Methods/Participants. We selected matched maternal and cord blood samples of 259 pregnan-
cies from the Edinburgh Reproductive Tissue BioBank (ERTBB; ethical approval REC09/S0704/3), collected 
between January 2010 – December 2014. The ERTBB stores anonymised tissue specifically collected for preg-
nancy research with the majority of samples collected at time of elective Caesarean section. Tissue samples are 
linked to a database containing clinical records. Our sample set comprised 102 lean (BMI 18.5–24.9 kg/m2), 
79 overweight (BMI 25.1–29.9 kg/m2), 45 obese (BMI 30–39.0 kg/m2) and 33 severely obese (BMI ≥ 40 kg/m2) 
women. Eligible women were Caucasian, had a singleton pregnancy, a normal booking ultrasound scan, and had 
not received any glucocorticoid therapy during their pregnancy. Clinical outcomes were extracted from clinical 
records. Macrosomia was defined as birthweight ≥4000 g at term (≥37 weeks).
Biological Samples. Trained research midwives and research technicians collected maternal and umbilical 
cord plasma at the time of delivery. Samples were collected in chilled EDTA vials and centrifuged within one hour 








(n = 33) p-value
Maternal age (years) 34.2 (5.0) 34.6 (6.2) 32.0 (5.2) 31.7 (5.0) 0.017
Maternal BMI (kg/
m2) 22.6 (1.6) 27.3 (1.4) 34.2 (2.8) 44.3 (3.6) <0.0001
Parity n (%)
Prim 27 (26.5) 13 (16.5) 8 (18.8) 8 (24.2) 0.15
Para 1 50 (49.0) 48 (60.8) 26 (57.8) 12 (36.4)
Para ≥ 2 25 (24.5) 18 (22.7) 11 (24.4) 13 (39.4)
Smoking n (%) <0.0001
Non smoker 96 (94.1) 75 (94.9) 44 (97.8) 22 (66.7)
Smoker 6 (5.9) 4 (5.1) 1 (2.2) 11 (33.3)
Labour onset n (%)
Spontaneous 3 (2.9) 3 (3.8) 3 (6.7) 2 (6.1) 0.019
Induced 2 (2.0) 0 (0) 1 (2.2) 4 (12.1)
Prelabour CS 97 (95.1) 76 (96.2) 41 (91.1) 27 (81.8)
Labour Type n (%)
Labour 9 (8.8) 3 (3.8) 3 (6.7) 5 (15.2) 0.212
Non-labour 93 (91.2) 76 (96.2) 42 (93.3) 28 (84.8)
Mode of Delivery n (%)
ElCS 93 (91.2) 76 (96.2) 42 (93.3) 28 (84.8) 0.102
SVD 0 0 0 1 (3.0)
Instrumental 2 (2.0) 0 1 (2.2) 2 (6.0)
EmCS in labour 3 (2.9) 3 (3.8) 2 (4.4) 2 (6.0)
Prelabour EmCS 4 (3.9) 0 0 0
Gestational age at delivery (days)
Mean (sd) 273.7 (8.1) 275.3 (7.0) 275.4 (8.5) 276.3 (7.6) 0.285
Baby gender n (%)
Male 55 (53.4) 40 (50.6) 27 (60) 20 (60.1) 0.607
Female 47 (46.1) 39 (49.4) 18 (40) 12 (36.4)
Birthweight (g) <0.0001
Mean (sd) 3442 (492) 3514 (546) 3851 (642) 3739 (555)
Macrosomia n (%) <0.0001
Yes 12 (11.8%) 11 (13.9) 20 (44.4%) 9 (26.5%)
Table 1. Maternal and Neonatal Characteristics. Parity was defined as ‘prim’ (no previous pregnancies delivered 
after 24 weeks), ‘para 1’ (one previous delivery after 24 weeks gestation) and ‘para ≥ 2’ (two or more previous 
deliveries after 24 weeks gestation). ‘Smokers’ were defined as those who considered themselves as current 
smokers. Macrosomia was defined as ≥ 4000 g. Data are mean (sd) or N (%). P-value is from one-way ANOVA 
for continuous variables, and chi-squared test for categorical variables. Missing data: n = 1 baby gender missing 
from offspring of severely obese Key: BMI (body mass index), CS (caesarean section), ElCS (elective caesarean 
section), EmCS (Emergency caesarean section), SVD (spontaneous vaginal delivery).
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Laboratory methods. Plasma steroid extraction and LC-MS/MS quantification: A method was developed 
to measure cortisol, cortisone, corticosterone and 11-dehydrocorticosterone simultaneously by liquid chroma-
tography tandem mass spectrometry (LC-MS/MS), using an ABSciex QTRAP® 5500 (Warrington, UK) oper-
ated in positive ion electrospray ionisation, with a Waters Acquity™ UPLC system (Manchester, UK). Analytes 
were extracted from plasma (200 µL) via liquid-liquid extraction (chloroform 10:1 (v/v)) with epi-cortisol (25 
ng; Steraloids, USA), epi-corticosterone (25 ng; Steraloids, USA) and 9,11,12,12 [2H4] cortisol (d4-cortisol; 25 ng: 
QMX Laboratories, UK) included as internal standards. Analytes were separated at 40 °C on a Waters SunfireTM 
C18 (2.1 × 150 mm; 3.5 μm) column (Manchester, UK) using an isocratic solvent system (70:30 of water with 
0.1% formic acid and acetonitrile with 0.1% formic acid) with a gradient run of 7.1 minutes. Mass spectral con-
ditions are demonstrated in Supplementary Table 1. Inter-assay precision and accuracy were within acceptable 
limits (Supplementary Table 3). The ratio of cortisol: cortisone was examined as a marker of 11β-HSD2 enzyme 
activity.
Statistical analysis. Data distribution was assessed for normality by visually assessing histograms. Data 
that were not normally distributed were normalized using the natural-log transformation. The independent t-test 
was used to test for differences between continuous variables and chi-squared test for categorical variables. The 
one-way ANOVA was used to compare change in hormone levels between different groups. In regression analysis 
we adjusted for covariates and confounding factors known to influence glucocorticoid levels including mode of 
delivery or labour16, 17, and gestational age18, 19, or that differed between groups in our sample such as offspring 
birthweight. Model 1 adjusted for gestational age at delivery, offspring birthweight and mode of delivery. Model 2 
adjusted for gestational age at delivery, offspring birthweight and labour status (labour or non-labour). Analysis 
was performed using SPSS v21 (IBM). Data in text are mean ± sd, and data in figures are mean ± SEM. Statistical 
significance was considered at p < 0.05.
Results
Demographics. Maternal and neonatal characteristics are demonstrated in Table 1. Obese and severely obese 
women were younger than lean women. Severely obese women had the highest numbers of current smokers. 
Women were well matched for parity, mode of delivery, gestational age at delivery and offspring gender. The 
most common mode of delivery in all BMI groups was elective Caesarean section, representative of samples in 
the ERTBB Induction of labour was highest in the severely obese group. Offspring birthweight was highest in the 
obese and severely obese groups. Lean women had significantly lower birthweight than both obese and severely 
obese women offspring. Rates of macrosomia were highest in the obese and severely obese group.
Figure 1. (a–d) Maternal and cord plasma levels. Cortisol (a), cortisone (b), corticosterone (c) and 
11-dehydrocorticosterone (d). Data are mean (sem); ***p < 0.0001.
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Relationship between maternal and cord hormone levels. Levels of cortisol and corticosterone were 
significantly higher in maternal blood than cord blood, whereas cortisone and 11-dehydrocorticosterone were 
significantly higher in cord blood than maternal blood (Fig. 1). Maternal and cord blood levels of all the moni-
tored steroid hormones were significantly positively correlated (Fig. 2). Maternal cortisol and corticosterone were 
also positively correlated with cord blood cortisone and 11-dehydrocorticosterone levels respectively (r = 0.454, 
p < 0.001; r = 0.437, p < 0.001).
Predictors of glucocorticoid levels at delivery. None of the hormones differed according to par-
ity, maternal smoking or maternal age. Maternal corticosterone was significantly higher in labouring than 
non-labouring deliveries and was associated with greater ‘stress’ (vaginal delivery higher than emergency 
and elective Caesarean sections) (Table 2). Cord corticosterone was significantly higher in labouring than 
non-labouring deliveries but did not differ with mode of delivery. Cord cortisone was significantly higher in 
labouring than non-labouring, and was significantly higher in deliveries associated with greater ‘stress’ (vaginal 
delivery higher than elective Caesarean section).
The association of maternal BMI with glucocorticoid hormone levels is demonstrated in Table 3. In the 
unadjusted analysis, increased maternal BMI was associated with lower maternal cortisol, corticosterone and 
11-dehydrocorticosterone. Maternal BMI remained significant as an independent predictor of these hormones in 
the adjusted analyses (Table 3). In cord blood, there were no associations between maternal BMI and glucocorti-
coid levels in the unadjusted or adjusted analyses.
Discussion
Our findings demonstrate that increased maternal BMI was associated with lower maternal cortisol, corticoster-
one and 11-dehydrocorticosterone measured at time of delivery. Despite significant positive correlations between 
maternal and cord blood hormone levels, maternal BMI was not associated with cord blood glucocorticoid levels.
Our observation that cortisol and corticosterone were higher in maternal than cord blood, and that cortisone 
and 11-dehydrocorticosterone were higher in cord than maternal blood supports the hypothesis that the placenta 
acts as a barrier to protect the fetus from overexposure to active glucocorticoids20. Indeed, maternal cortisol 
and corticosterone were positively correlated with cortisone and 11-dehydrocorticosterone respectively. We also 
Figure 2. (a–d) Correlations of maternal and cord blood levels. Cortisol (r = 0.392, p < 0.0001; a), cortisone 
(r = 0.432, p < 0.0001; b), corticosterone (r = 0.437, p < 0.0001; c), 11-dehydrocorticosterone (r = 0.481, 
p < 0.0001; d).
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found a significant positive correlation between maternal and cord hormone levels (for all hormones), consistent 
with studies showing that maternal plasma and amniotic fluid cortisol levels are correlated during pregnancy6–8, 21.
Our findings are consistent with literature showing that labour and mode of delivery are associated with both a 
maternal and fetal endocrine (glucocorticoid hormone) stress response. For example, both higher maternal and cord 
blood cortisol levels have been reported where delivery was by vaginal or emergency Caesarean section (i.e. where 
labour had occurred), compared with delivery by elective Caesarean section (i.e. pre-labour)10, 12, 14. Our finding of 
higher corticosterone (but not cortisol) in labouring cord samples was in-keeping with a previous study14 who found 
highest corticosterone levels in vaginal deliveries, followed by emergency caesarean deliveries (who would have 
laboured), and lowest levels in elective caesarean deliveries (no labour). It has been suggested that this may be due to 
developmental changes in fetal glucocorticoid synthesis with preferential secretion of corticosterone in utero, and a 
shift towards the adult pattern of preferential cortisol synthesis after delivery14. These observations suggest that fetal 
adrenal corticosterone may be a better marker of fetal stress14. In addition, we showed for the first time that mater-
nal corticosterone levels were higher in labouring than non-labouring women, which may suggest this hormone is 
released into the maternal circulation in response to the ‘stress’ associated with labour. However, we did not replicate 
previous findings of higher cord cortisol in cases where labour has occurred10–12; a large proportion of our subjects 
were delivered by elective Caesarean section, and more labouring samples may be required to replicate this finding.
Smith et al.,11 found no effect of maternal mood or anxiety disorders on cord blood cortisol at delivery, and 
suggested that conditions at delivery per se overwhelm the possible smaller diagnosis of treatment-related differ-
ences in hypothalamic-pituitary-adrenal axis responses during pregnancy. However, they did not adjust for mode 
of delivery or labour. Our data suggest that even in the ‘controlled’ conditions of elective Caesarean section, in 
accord with these findings11 the conditions at delivery per se may overwhelm the effects of BMI on cord cortisol. 
While detailed studies conducted at elective Caesarean section have informed our knowledge of maternal, placen-
tal and fetal glucose transfer22 such studies are less likely to be informative about glucocorticoid transfer between 
the maternal, placental and fetal unit.
A novelty of our study is the measurement of maternal corticosterone levels. In rodents, corticosterone is the 
major circulating glucocorticoid hormone and a handful of studies have measured maternal and fetal glucocor-
ticoid levels in animal models of obesity in pregnancy. Two studies in mice and rats fed a high-fat diet reported 
increased levels of maternal corticosterone23, 24 suggesting that a high-fat diet acts as a stressful challenge during 
rodent pregnancy. However, in contrast to both of these studies, another study in rats measured rhythmic 21-hour 
profiles of maternal and fetal corticosterone and 11-dehydrocorticosterone, and found that these were unaffected 
by obesity25. Whilst rodent studies can more easily control for complications of labour and delivery than human 
studies and so are important comparisons for the effect of obesity on glucocorticoid levels, the species in maternal 
glucocorticoid responses to obesity/high fat diet need to be considered in interpreting the observations.
Blood Type Hormone
Labour Status Mode of Delivery
Labour (n = 16)
Non-labour 






(n = 6) p-value
Maternal Blood
11-dehydrocorticosterone 7.7 (3.8) 6.9 (3.1) 0.59 6.9 (3.1) 6.8 (3.4) 9.9 (4.2) 0.099
Corticosterone 34.1 (30.2) 20.1 (11.6) 0.006 20.1 (11.6) 24.0 (16.3) 57.4 (43.0)  <0.0001
Cortisone 198.7 (77.8) 202.5 (77.4) 0.857 202.1 (77.4) 184.9 (57.9) 230.9 (111.7) 0.637
Cortisol 1086.3 (558.4) 928.7 (398.0) 0.293 928.7 (398.0) 1026.6 (597.2) 1225.7 (473.5) 0.266
Cord Blood
11-dehydrocorticosterone 26.3 (19.7) 20.4 (16.5) 0.076 20.4 (16.5) 22.4 (15.1) 35.5 (27.3) 0.072
Corticosterone 15.5 (7.6) 12.2 (6.8) 0.046 12.2 (6.8) 14.2 (7.4) 18.4 (8.0) 0.058
Cortisone 661.2 (342.5) 442.8 (226.6) 0.002 442.8 (226.6) 612.7 (332.9) 774.4 (368.3) 0.004
Cortisol 145.7 (100.1) 124.4 (83.0) 0.35 124.4 (83.0) 140.1 (114.9) 158.9 (58.6) 0.364
Table 2. Hormone levels by labour status and mode of delivery. Data are mean (sd). P-value from Student’s 




Unadjusted Model 1 Model 2
β 95% CI p βa 95% CI pa βa 95% CI pa
Maternal Blood
11-DHC −0.011 (−0.019 to −0.004) 0.003 −0.014 (−0.022 to −0.007)  < 0.0001 −0.014 (−0.022 to −0.007)  <0.0001
Corticosterone −0.010 (−0.019 to −0.002) 0.019 −0.12 (−0.021 to −0.004) 0.006 −0.013 (−0.022 to −0.004) 0.004
Cortisone 0.0000052 (−0.007 to 0.007) 0.999 −0.003 (−0.009 to 0.004) 0.442 −0.003 (−0.009 to 0.004) 0.448
Cortisol −0.009 (−0.017 to −0.001) 0.023 −0.011 (−0.019 to −0.003) 0.009 −0.011 (−0.019 to −0.003) 0.007
Cord Blood
11-DHC 0.004 (−0.007 to 0.016) 0.472 0.005 (−0.007 to 0.016) 0.711 0.004 (−0.008 to 0.016) 0.358
Corticosterone 0.000058 (−0.008 to −0.009) 0.989 −0.001 (−0.010 to 0.007) 0.739 −0.002 (−0.011 to 0.007) 0.672
Cortisone 0.006 (−0.003 to 0.016) 0.168 0.005 (−0.004 to 0.014) 0.306 0.004 (−0.005 to 0.014) 0.377
Cortisol 0.005 (−0.005 to 0.016) 0.303 0.002 (−0.009 to 0.012) 0.769 0.001 (−0.009 to 0.012) 0.800
Table 3. Associations of maternal BMI with hormone levels. Model 1: adjusted for gestational age at delivery, 
offspring birthweight and mode of delivery. Model 2: adjusted for gestational age at delivery, offspring 
birthweight and labour status (labour or non-labour).
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Strengths of our study are the large sample size, with a high proportion of elective caesarean deliveries, and 
a wide range of maternal BMI. Our finding of higher birthweight in offspring of obese women is representative 
of what is expected in this sub-population of pregnant women26. Our samples were analysed by liquid chroma-
tography tandem mass spectrometry, which is the gold standard for measuring glucocorticoid hormones, and 
facilitated the simultaneous analysis of multiple hormones from a small sample volume (200 uL). We are also the 
first to describe the relationship of all these glucocorticoid hormones between maternal and cord blood.
A limitation of this study is that, like others11, 12 our cord blood samples were mixed cord artery and vein 
meaning we were unable to conduct a detailed assessment of the placental and fetal contribution to corticos-
terone metabolism. This was due to limited availability of cord blood in our setting, where delayed cord clamp-
ing is practiced and clinical bloods are required for blood gas testing; thus, the volume of blood available for 
research purposes was limited. Some studies have demonstrated differences in levels of cortisol and corticoster-
one between cord artery and vein10, 14. For example, in a study of 256 matched arterial and venous cord blood 
samples, Wynne-Edwards et al., reported an increase in both cortisol and corticosterone from the venous to the 
arterial circulation, suggesting that the fetal adrenal contributed corticosteroids to the arterial circulation while 
placental 11β-HSD2 was clearing both corticosteroids14. Ex vivo studies using the placental perfusion model20 
combined with deuterated cortisol tracers27 would allow more details assessment of the fetal and placental con-
tribution to corticosteroid levels.
In conclusion, our study suggests that maternal glucocorticoids are lower at delivery in obese pregnancy, and 
that conditions at delivery may overwhelm any effect of BMI on cord glucocorticoid levels. This should be consid-
ered in studies investigating glucocorticoids at delivery. Though conditions at delivery may overcome any poten-
tial negative effects of low glucocorticoids on the fetus in the short-term, this may not preclude the longer-term 
effects of lower glucocorticoid exposure during obese pregnancy and further studies are needed to examine this.
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